Literature DB >> 1696117

The effect of local converting enzyme inhibition on the dilator response to substance P in the human forearm.

N Benjamin1, D J Webb.   

Abstract

It has been proposed that angiotensin converting enzyme (ACE) may play a part in the metabolism of substance P. Reduced metabolism following treatment with ACE inhibitors may cause accumulation of substance P to produce the adverse effect of cough. It has been shown in this study that, in contrast to angiotensin I and bradykinin, inhibition of local vascular ACE does not interfere with the vascular effects of substance P on forearm resistance vessels when this peptide is infused into the brachial artery of normal volunteers. These results suggest that endothelial ACE plays little part in the metabolism of intravascular substance P.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1696117      PMCID: PMC1380183          DOI: 10.1111/j.1365-2125.1990.tb03702.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  11 in total

1.  Local inhibition of converting enzyme and vascular responses to angiotensin and bradykinin in the human forearm.

Authors:  N Benjamin; J R Cockcroft; J G Collier; C T Dollery; J M Ritter; D J Webb
Journal:  J Physiol       Date:  1989-05       Impact factor: 5.182

Review 2.  The neuropharmacology of capsaicin: review of some recent observations.

Authors:  S H Buck; T F Burks
Journal:  Pharmacol Rev       Date:  1986-09       Impact factor: 25.468

3.  Enalapril-induced cough.

Authors:  D Webb; N Benjamin; J Collier; B Robinson
Journal:  Lancet       Date:  1986-11-08       Impact factor: 79.321

4.  Increased cough reflex associated with angiotensin converting enzyme inhibitor cough.

Authors:  R W Fuller; N B Choudry
Journal:  Br Med J (Clin Res Ed)       Date:  1987-10-24

5.  Angiotensin-converting enzyme: vascular endothelial localization.

Authors:  P R Caldwell; B C Seegal; K C Hsu; M Das; R L Soffer
Journal:  Science       Date:  1976-03-12       Impact factor: 47.728

6.  The disappearance of bradykinin and eledoisin in the circulation and vascular beds of the cat.

Authors:  S H Ferreira; J R Vane
Journal:  Br J Pharmacol Chemother       Date:  1967-06

7.  Hydrolysis of substance P and its analogs by angiotensin-converting enzyme from rat lung. Characterization of endopeptidase activity of the enzyme.

Authors:  H Yokosawa; S Endo; Y Ohgaki; J Maeyama; S Ishii
Journal:  J Biochem       Date:  1985-11       Impact factor: 3.387

8.  Carboxyl-terminal tripeptidyl hydrolysis of substance P by purified rabbit lung angiotensin-converting enzyme and the potentiation of substance P activity in vivo by captopril and MK-422.

Authors:  M A Cascieri; H G Bull; R A Mumford; A A Patchett; N A Thornberry; T Liang
Journal:  Mol Pharmacol       Date:  1984-03       Impact factor: 4.436

9.  Vasodilatation by calcitonin gene-related peptide and by substance P: a comparison of their effects on resistance and capacitance vessels of human forearms.

Authors:  J R McEwan; N Benjamin; S Larkin; R W Fuller; C T Dollery; I MacIntyre
Journal:  Circulation       Date:  1988-05       Impact factor: 29.690

10.  The concentration of angiotensins I and II in blood from the pulmonary artery and left ventricle of man.

Authors:  P F Semple
Journal:  J Clin Endocrinol Metab       Date:  1977-05       Impact factor: 5.958

View more
  4 in total

1.  Effect of neutral endopeptidase inhibitor on airway function and bronchial responsiveness in asthmatic subjects.

Authors:  G M Nichol; B J O'Connor; J M Lecomte; K F Chung; P J Barnes
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

2.  Effect of aspirin on vasodilation to bradykinin and substance P in patients with heart failure treated with ACE inhibitor.

Authors:  Andrew P Davie; John J V McMurray
Journal:  Br J Clin Pharmacol       Date:  2002-01       Impact factor: 4.335

3.  The pharmacokinetic and pharmacodynamic interactions of ramipril with propranolol.

Authors:  J M van Griensven; M Seibert-Grafe; H C Schoemaker; M Frölich; A F Cohen
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

4.  Substance P increases sympathetic activity during combined angiotensin-converting enzyme and dipeptidyl peptidase-4 inhibition.

Authors:  Jessica K Devin; Mias Pretorius; Hui Nian; Chang Yu; Frederic T Billings; Nancy J Brown
Journal:  Hypertension       Date:  2014-02-10       Impact factor: 10.190

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.